Abstract:To predict the risk of pancreatic cancer in patients with diabetes is crucial; the study aims to establish a novel prediction model for pancreatic cancer risk among patients with diabetes using real‐world clinical data. Introduction Pancreatic cancer is associated with poor prognosis. Considering the increased global incidence of diabetes cases and that individuals with diabetes are considered a high‐risk subpopulation for pancreatic cancer, it is critical to detect the risk of pancreatic cancer within populations of person living = with diabetes. This study aimed to develop a novel prediction model for pancreatic cancer risk among patients with diabetes, using = a real‐world database containing clinical features and employing numerous artificial intelligent approach algorithms. Methods This retrospective observational study analyzed data on patients with Type 2 diabetes from a multisite Taiwanese EMR database between 2009 and 2019. Predictors were selected in accordance with the literature review and clinical perspectives. The prediction models were constructed using machine learning algorithms such as logistic regression, linear discriminant analysis, gradient boosting machine, and random forest. Results The cohort consisted of 66,384 patients. The Linear Discriminant Analysis (LDA) model generated the highest AUROC of 0.9073, followed by the Voting Ensemble and Gradient Boosting machine models. LDA, the best model, exhibited an accuracy of 84.03%, a sensitivity of 0.8611, and a specificity of 0.8403. The most significant predictors identified for pancreatic cancer risk were glucose, glycated hemoglobin, hyperlipidemia comorbidity, antidiabetic drug use, and lipid‐modifying drug use. Conclusion This study successfully developed a highly accurate 4‐year risk model for pancreatic cancer in patients with diabetes using real‐world clinical data and multiple machine‐learning algorithms. Potentially, our predictors offer an opportunity to identify pancreatic cancer early and thus increase prevention and invention windows to impact survival in diabetic patients.

S101 Prevalence of Gastroparesis in Patients With Chronic Pancreatitis and Predictive Factors: A Novel Prediction Model Using Supervised Machine Learning

Predicting Response to Neuromodulators or Prokinetics in Patients With Suspected Gastroparesis Using Machine Learning: The "BMI, Infectious Prodrome, Delayed GES, and No Diabetes" Model

Prediction of the Severity of Acute Pancreatitis Using Machine Learning Models.

Machine learning-based prediction of gastroparesis risk following complete mesocolic excision

Machine learning for post-acute pancreatitis diabetes mellitus prediction and personalized treatment recommendations

Delayed gastric emptying risk stratification in patients with pancreatic ductal adenocarcinoma after pancreatoduodenectomy: An international validation cohort study

S180 Prediction of New-Onset Diabetes Following Acute and Chronic Pancreatitis Using Machine Learning Algorithms: Analysis of Large Real-World Data

Multi-step validation of a Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis prediction system integrating multi-modal data: A multi-center study

Development and validation of a risk prediction model and scoring system for post-endoscopic retrograde cholangiopancreatography pancreatitis

Early Prediction of Severe Acute Pancreatitis Using Machine Learning

Machine Learning Predictive Model for Aspiration Risk in Early Enteral Nutrition Patients with Severe Acute Pancreatitis

Development and validation of a machine learning-based, point-of-care risk calculator for post-ERCP pancreatitis and prophylaxis selection

Development and validation of a practical clinical risk prediction model for post-endoscopic retrograde cholangiopancreatography pancreatitis

Development and Validation of a Survival Prediction Model for Patients with Pancreatic Cancer

A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning

A prediction nomogram for postoperative gastroparesis syndrome in right colon cancer: a retrospective study

Guiding post-pancreaticoduodenectomy interventions for pancreatic cancer patients utilizing decision tree models

S2298 Gastroparesis as an Early Manifestation of Gastric Cancer: A Descriptive Analysis

Predictive machine learning models for survival outcomes in patients with pancreatic cancer.

Common Pathophysiological Mechanisms and Treatment of Diabetic Gastroparesis

Early prediction of acute gallstone pancreatitis severity: a novel machine learning model based on CT features and open access online prediction platform